Hunter-Fleming Ltd Company Profile

20:59 EDT 25th September 2018 | BioPortfolio

Hunter-Fleming is an innovative pharmaceutical development company, specializing in the development of radically novel therapeutics relevant to the treatment of acute and chronic inflammatory degenerative disorders - disorders with significant unmet medical needs. The Company’s initial focus is on neurodegenerative disorders of the central nervous system (CNS) and autoimmune disorders, areas in which the management has a proven track record in the successful development of novel compounds.Hunter-Fleming is building a broad, balanced portfolio of innovative development projects and technologies with leading academic groups and the pharmaceutical industry through licensing agreements, acquisitions, and in-house innovations which have already resulted in a proprietary series of 12 patent families.Through its access to enabling academic technologies, Hunter-Fleming has identified a potential for the design of novel second generation neuroprotective compounds. Hunter-Fleming has also established a joint venture (Hunter-Oncology Ltd) with Queen's University (Belfast) Cancer Centre to develop novel, innovative anti-cancer agents.


Regus House1 Friary
Temple Quay
United Kingdom


Phone: 44 (0) 117 900 8265
Fax: 44 (0) 117 900 8424

News Articles [77 Associated News Articles listed on BioPortfolio]

Gail Fleming appointed new RPS director of education

In her new role, Gail Fleming will lead the design and delivery of the Royal Pharmaceutical Society’s educational programmes and strategy.

[Perspectives] Kenneth Fleming: making the global case for pathology

Some years ago, and while still occupying a senior post in the administration of medical training and research at the UK's University of Oxford, pathologist Kenneth Fleming was at a meeting in Bangkok...

EXCLUSIVE: John Fleming Settles into Government Role with Full Focus on Reducing M.D. Burden

Rajiv LeventhalDr. Fleming sat down with Healthcare Informatics to discuss his role in the government, where things stand on reducing clinician burden, and why he thinks patient empowerment is so impo...

Sex offender tells paedophile hunter he’s got the wrong man – until WhatsApp message comes back to haunt him –

Bath ChronicleSex offender tells paedophile hunter he's got the wrong man - until WhatsApp message comes back to haunt sex offender told a paedophile hunter he'd got the wrong man - u...

James Hunter Lawrie

bmj;361/may04_9/k1940/FAF1faPioneering paediatric surgeon James Hunter Lawrie made a major contribution to the development of surgery and to medical education in Africa, the Middle East, and...

Basket Welcomes Hunter Powell as Senior Vice President of Engineering

ARLINGTON, Va., May 23, 2018/PRNewswire/ --  Basket, the largest shopper powered grocery platform announced today its appointment of Hunter Powell as Senior Vice Read more...

NASA's New Planet Hunter Snaps Initial Test Image, Swings by Moon Toward Final Orbit

NewsNASA's next planet hunter, the Transiting Exoplanet Survey Satellite (TESS) successfully completing a lunar flyby on May 17.

Odors are perceived the same way by hunter-gatherers and Westerners

Previous research has shown the hunter-gatherer Jahai are much better at naming odors than Westerners. They even have a more elaborate lexicon for it. New research by language scientists show that des...

Drugs and Medications [63 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Fleming County Hospital Home Medical Equipment]


Nephrocaps [Fleming & Company, Pharmaceuticals]


Nephrocaps-qt [Fleming & Company, Pharmaceuticals]


Scent-a-way anti-perspirant [Hunter's Specialties]

Scent-A-Way Extended Protection Anti-Perspirant

Nephrocaps [American Health Packaging]


PubMed Articles [41 Associated PubMed Articles listed on BioPortfolio]

Infective Endocarditis: A Hunter New England Perspective.

Infective endocarditis is a severe infection conferring significant morbidity and mortality. It is associated with geographical variation, complicating diagnosis and treatment of patients in a standar...

William Hunter and Lymphatics.

William Hunter along with his brother, John, and their colleagues William Hewson, William Cruikshank and John Sheldon made a large contribution to understanding of lymphatic vessels. Hewson, Cruikshan...

Bow Hunter's syndrome caused by compression of the subaxial vertebral artery - surgical technique of antero-lateral decompression (video).

Bow hunter's syndrome (BHS) is a rare clinical condition. It is caused by dynamic com-pression of the vertebral artery either at the level of the transverse foramina (V2 segment) or at the atlanto-axi...

C2-3 Anterior cervical arthrodesis in the treatment of Bow Hunter's Syndrome: Case report and review of the literature.

Bow Hunter's Syndrome (BHS) or rotational vertebral artery occlusion (RVAO) is a rare syndrome of vertebrobasilar insufficiency due to compression or occlusion of the contralateral vertebral artery wi...

The genomic history of southeastern Europe.

Farming was first introduced to Europe in the mid-seventh millennium bc, and was associated with migrants from Anatolia who settled in the southeast before spreading throughout Europe. Here, to unders...

Clinical Trials [25 Associated Clinical Trials listed on BioPortfolio]

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Study HGT-HIT-094 is a multicenter study designed to determine the effect on clinical parameters of neurodevelopmental status of monthly IT administration of idursulfase-IT 10 mg for 12 mo...

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

This long-term study will provide Elaprase treatment to children enrolled in this study and will utilize data from both enrolled patients and Hunter Outcome Survey (HOS) patient registry d...

Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)

The purpose of this non-interventional, observational study which is conducted in Mexico is to evaluate the safety profile of elaprase (idulsurfase) in participants with hunter syndrome (m...

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

The objective of this study is to evaluate the effect of anti-idursulfase IgG, IgM & IgE antibodies on idursulfase safety (measured by infusion related adverse events) between patients who...

Pilot Prospective Study of Two Methods of Revascularization of the Femoral Artery (SFA): Stenting in the SFA, and Stenting of the SFA, Supplemented by Fasciotomy in Hunter Channel.

Comparison of two methods for revascularization of the superficial femoral artery: stenting of the superficial femoral artery vs. stenting of the superficial femoral artery supplemented wi...

Companies [25 Associated Companies listed on BioPortfolio]

Hunter-Fleming Ltd

Hunter-Fleming is an innovative pharmaceutical development company, specializing in the development of radically novel therapeutics relevant to the treatment of acute and chronic inflammatory degenera...

Hunter Fleming

Hunter-Fleming is a pharmaceutical development company which specializes in bridging the product development gap between world-wide academic research and pharmaceutical marketing companies

Hunter Medical Inc.

Hunter Medical, Inc. was founded in 2013 by Lee Hunter M.D., M.B.A., a board-certified orthopaedic surgeon who specializes in surgery of the upper extremity, particularly the elbo...

Global Hunter Securities

Global Hunter Securities, LLC is a full service investment bank focusing on middle market corporate and institutional clients around the world. The firm provides insightful resear...

Hunter Wise Financial Group, LLC

Hunter Wise Financial Group, LLC is a specialized investment bank providing the highest quality level of corporate financing, merger, acquisition, divestiture and advisory services. The Company's clie...

More Information about "Hunter-Fleming Ltd" on BioPortfolio

We have published hundreds of Hunter-Fleming Ltd news stories on BioPortfolio along with dozens of Hunter-Fleming Ltd Clinical Trials and PubMed Articles about Hunter-Fleming Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hunter-Fleming Ltd Companies in our database. You can also find out about relevant Hunter-Fleming Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record